Skip to content
TFS TFS HealthScience | Contract Research Organization | Global Resourcing Provider | CRO
Request a proposal

Ophthalmology

Therapeutic expertise Ophthalmology

Ophthalmology clinical trial expertise across retinal, corneal and ocular surface diseases

Successful ophthalmic trials require precise execution of complex endpoints and strong patient engagement. Our dedicated ophthalmology team bridges the gap between protocol design and site delivery- providing detailed investigator training on masking integrity, operationalizing masking requirements, standardizing imaging workflows, and overseeing certified visual acuity procedures. By actively partnering with sites and study participants to minimize burden, we ensure high data quality and strong long-term retention.
Talk to our dermatology team

70+

Completed trials

690+

Investigator sites across 30+ countries

5,000+

Patients enrolled

Multi-region reach for complex ophthalmology trials

Top-tier retina, cornea and glaucoma investigative sites are finite and highly competitive, especially, in rare ocular indications where narrow eligibility criteria lead to high screen failure rates. Our team strategically breaks through these barriers with a multi-regional approach. Spanning 30+ countries with robust infrastructure across North America, Europe, the UK, Australia and Latin America, we execute parallel regulatory pathways and tap broader patient pools, driving faster study startup and predictable recruitment.

Retina & Posterior Segment Diseases
Age-Related Macular Degeneration (AMD) (Wet and Dry) · Diabetic Retinopathy · Diabetic Macular Edema (DME) · Inherited Retinal Diseases (IRD), including Stargardt’s Disease and Retinitis Pigmentosa · Geographic Atrophy (GA)

Corneal & Anterior Segment Diseases
Dry Eye Disease (DED) · Blepharoconjunctivitis · Keratoconjunctivitis · Corneal Cross-Linking for Keratoconus · other corneal disorders

Glaucoma & Ocular Hypertension
Primary Open-Angle Glaucoma · Ocular Hypertension · Minimally Invasive Glaucoma Surgery (MIGS) devices, including MicroShunts, Cypass, Xen and Tube Shunts

Ophthalmic Devices & Surgical Innovations
Intraocular Lenses (IOLs) · Artificial Iris · Drug-Eluting Ophthalmic Devices · Lens Devices for Glaucoma · Anesthesia Devices for Ophthalmology

Ocular Inflammatory & Rare Ophthalmic Disorders
Uveitis · Uveal Melanoma · Optic Neuropathy

Bhakti Patel

Executive Director, Project Delivery

“Successful ophthalmology trials start with thoughtful protocol design and a clear understanding of the patient journey. By partnering with sponsors early, we help shape study strategies, operational plans, and site training programs that support high-quality execution while keeping the patient experience at the center, ultimately driving better patient outcomes.”

Ophthalmology project leaders embedded in your study, keeping patient experience part of every planning decision.

Know your team

How we secure your clinical pathway

Clinical continuum

Built-in flexibility, from a single CRA to full global trials.

Strategic resourcing, FSP and full-service clinical development, working as one team. Scale capacity across 40 countries, eliminating vendor handoffs while preserving protocol knowledge in the room the whole way through.

Therapeutic depth

Fast decisions through specialized clinical depth.

We restrict our focus to five complex therapeutic areas. Our specialized leads theyhold direct decision-making authority, fast-tracking approvals and solving site bottlenecks with scientific authority.

Teams that stay

True peers, driven by scientific urgency.

TFS holds an 88% retention rate, 8 points above the industry average. That means the senior scientific peer who joins your study is still there at database lock.

Trial security

Risk flagged early. Execution made visible.

Rooted in our Swedish heritage, we bring disciplined methodology and transparent communication to every study. We deliver real-time data integrity, flag protocol issues before they cost you time, and maintain regulatory compliance at every milestone.

Medical and operational
ophthalmology leadership

Marcia Swank

VP, Head of Ophthalmology

Bhakti Patel

Senior Director, Project Delivery

Jessica Wessel

Senior Director, Project Delivery

One team, whether you need a single specialist or a full trial.

Clinical development

Access specialized clinical experts who integrate directly into your internal teams, matching your operational demands as they shift.
— Rapid deployment of validated
clinical professionals.

— Flexible capacity management 
tailored to pipeline shifts.
Phase I to III Phase IV & RWE

Strategic solutions

We embed life sciences expertise wherever your programme needs it: a single expert consultant, a dedicated FSP team, a hybrid model or a fully managed function. Every option draws on 60,000+ active professional profiles and runs on one continuum, with built-in flexibility, trial security and senior teams that stay from day zero.
— Expert consultants matched to your study, on average within five days.

— Dedicated FSP teams, line-managed by TFS and working to your SOPs.

— Hybrid models that combine FSP and full service under one governance.

— Managed functions we run for you, from oversight to systems.
Explore solutions

End-to-end delivery

Full-service trial execution, backed by therapeutic depth and teams that stay.
— Full-lifecycle protocol management 
from design to database lock.

— Scientific leadership across 5 specialized 
therapeutic areas.

— Stable project teams ensuring continuous 
data quality and safety.
Explore solution

Quality Management

Three services. One independent quality function, standalone or embedded across your clinical portfolio.
— Audit & programme management: risk-based GxP audits to detect risks early and drive continuous improvement.

— Inspection readiness: targeted assessments, mock inspections and SME preparation for regulatory scrutiny.

— Quality oversight: ICH E6(R3)- and ICH E8(R1)-aligned oversight across studies and vendors.
Explore solution

Securing the path for sponsors’ science.

View all

The resourcing decision : Full-service, FSP or specialist. Which one actually fits your programme?

Read case study

The new endpoints reshaping oncology trial design

Read case study

Juneteenth and the next chapter of medicine

Read case study

This Pride Month see the life behind every number

Read case study

Updates to keep your trials
moving forward.

News VERIGRAFT and TFS HealthScience partner on pivotal Phase II/III trial of personalized tissue-engineered vein for chronic venous insufficiency
Read news
News Our 2025 sustainability year in review: the highlights
Read news
News Europe's clinical development landscape: does the EU hold a busted flush or a full house?
Read news
News Expanding the Frontiers of Neuroscience: TFS Strengthens Its Gene Therapy Portfolio in Neurodegenerative Diseases
Read news
View all

Clinical operations & outsourcing FAQs.

What clinical outsourcing models does TFS provide?
We deliver three modular frameworks under a single contract: Strategic Resourcing, Functional Service Provider (FSP), and Full-Service Trials. This model elasticity allows you to scale clinical capacity fluidly as your pipeline demands, eliminating vendor handoffs.

What is the geographic footprint and reach of TFS?
Founded in Lund, Sweden, we operate as a global CRO with active regulatory and clinical reach across 40 countries. We combine comprehensive multi-region execution with specialized infrastructure and investigator networks across Europe and the Nordics.

How does TFS maintain clinical study continuity?
We maintain an industry-leading CRA turnover rate of 14%, significantly outperforming the 20% sector average. This team stability ensures consistent protocol knowledge, reduces management burden, and protects your data integrity.

Which therapeutic areas does TFS specialize in?
We concentrate our medical, clinical, and regulatory capabilities exclusively within five core areas: Dermatology, Internal Medicine, Neuroscience, Oncology, and Ophthalmology, backed by a track record of 1,800+ completed trials.